Brief: Galera Reports Fourth Quarter And Full Year 2021 Financial Results And Recent Corporate Updates
March 10 (Reuters) - Galera Therapeutics Inc GRTX.O :
* GALERA REPORTS FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL
RESULTS AND RECENT CORPORATE UPDATES
* Q4 LOSS PER SHARE $0.64
* DATA READOUTS FROM AESOP IN ESOPHAGITIS AND GRECO-1 IN
LUNG
CANCER EXPECTED IN 1H 2022
* STRONG CASH POSITION OF $71M WITH EXPECTED CASH RUNWAY
INTO 2H
2023
Source text for Eikon: ID:nGNX5RlWyt
Further company coverage: GRTX.O
Recent news on Galera Therapeutics
See all newsBrief: Galera Therapeutics Says Nasdaq Will Delist Co's Common Stock By Filing Form 25 With SEC On Sept 4
Brief: Galera Announces Board Approval Of Complete Liquidation And Dissolution
Brief: Galera Therapeutics Receives Written Notice From Nasdaq Indicating That Nasdaq Hearings Panel Determined To Delist Co’s Shares
Brief: Alpha Pharma Investments Llc Reports 10.899% Passive Stake In Galera Therapeutics
Brief: Galera Adopts Limited Duration Stockholder Rights Agreement